2-(2-(2-(2-(1,3-dioxo-3a,4,7,7a-tetrahydro-1H-isoindol-2(3H)-yl)ethoxy)ethoxy)ethyl)-3a,4,7,7a-tetrahydro-2H-isoindole-1,3-dione

ID: ALA4079481

PubChem CID: 137651761

Max Phase: Preclinical

Molecular Formula: C22H28N2O6

Molecular Weight: 416.47

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1C2CC=CCC2C(=O)N1CCOCCOCCN1C(=O)C2CC=CCC2C1=O

Standard InChI:  InChI=1S/C22H28N2O6/c25-19-15-5-1-2-6-16(15)20(26)23(19)9-11-29-13-14-30-12-10-24-21(27)17-7-3-4-8-18(17)22(24)28/h1-4,15-18H,5-14H2

Standard InChI Key:  OJUOQWIEFWANDB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   15.6670  -11.2137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6670  -12.0309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3722  -12.4353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3722  -10.8010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0775  -11.2137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0775  -12.0319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8556  -12.2848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3367  -11.6228    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.8557  -10.9609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1082  -10.1838    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.1081  -13.0620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.1539  -11.6228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5624  -12.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3796  -12.3306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.7882  -11.6229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6054  -11.6229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0140  -12.3306    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.8312  -12.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2398  -11.6229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0570  -11.6229    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.5319  -12.2831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5319  -10.9609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2770  -10.1845    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.2775  -13.0597    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.3091  -11.2133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3081  -12.0309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0117  -12.4383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7208  -12.0326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7218  -11.2151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0137  -10.8032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  9 10  2  0
  7 11  2  0
  8 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 26  1  0
 25 22  1  0
 22 20  1  0
 22 23  2  0
 21 24  2  0
 25 26  1  0
 25 30  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4079481

    ---

Associated Targets(Human)

NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PA-1 (704 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.47Molecular Weight (Monoisotopic): 416.1947AlogP: 0.92#Rotatable Bonds: 9
Polar Surface Area: 93.22Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 0.49CX LogD: 0.49
Aromatic Rings: Heavy Atoms: 30QED Weighted: 0.32Np Likeness Score: -0.41

References

1. Kumar A, Banerjee S, Roy P, Sondhi SM, Sharma A..  (2017)  Solvent free, catalyst free, microwave or grinding assisted synthesis of bis-cyclic imide derivatives and their evaluation for anticancer activity.,  27  (3): [PMID:28011220] [10.1016/j.bmcl.2016.12.031]

Source